Securities lend money to lend ... Debt Stock Investment `Max`
"Customers are lousy to borrow money, but we have no money to borrow.
The credit limit is full, and we are sad." A securities company employee complained that it has been a sigh for the rapidly growing number of credit customers.
Securities companies can only lend money within their own capital limits because their solvency is virtually depleted as credit financing applications soar.
The general public who invested in stocks because of the bullish stock market has exceeded the record high.
According to the Financial Investment Association of Korea (KITA) on Friday, the balance of the credit crunch has reached 11 trillion won for the first time in history, reaching 11,648 billion won on the 26th, and 11,866 billion won on the 29th.
Until just a year ago, the balance of credit loans was only 7.129 trillion won.
It has increased by 55% in about a year.
The amount of the secured loan secured by the secured funds as collateral has also been steadily rising to 17 trillion won since April 8 from 17.767 trillion won on the 29th.
The amount of the secured loan secured by the securities was only 13 trillion won until the end of last year.
As the number of investors in credit financing increased, so did the movement of securities firms.
Credit loans are at least 7% interest rate, which can be a huge revenue source for securities firms.
Therefore, some securities firms are considering consideration for a capital increase to increase credit limit.
"The number of customers who inquire whether they can buy stocks with credit mainly for pharmaceutical, biotech or theme stocks has increased a lot," said an employee who met at a brokerage branch in Chungcheong, Seoul on 30th. "Once you open an account, "He said.
Concerns over credit bustle are also growing.
"Considering the trend of interest rate hikes and possible adjustment of future stock markets, risk management is essential for individual investors," said an investment adviser.
'경제' 카테고리의 다른 글
Thinking about KOSDAQ - supply and demand (0) | 2018.01.31 |
---|---|
Stock market declines from bond market (0) | 2018.01.31 |
KRX300, KOSDAQ stocks are biotyped (0) | 2018.01.31 |
동구 바이오 시력 30억달러 CMO 라인 강화를 위한 코스닥 IPO (0) | 2018.01.30 |
한국의 Q4 GDP 성장률은 전년 대비 0.2 % 하락한 2017 년 대비 3.1 % 상승 (0) | 2018.01.29 |